NGL Fine Chem

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE887E01022
NSEID: NGLFINE
BSEID: 524774
View on NSE | View on BSE

INR

2,216.95

37.6 (1.73%)

BSENSE

Feb 09

BSE+NSE Vol: 11.77 k

{
  "main_header": {
    "sid": 700623,
    "name": "NGL Fine Chem",
    "stock_name": "NGL Fine Chem",
    "full_name": "NGL Fine Chem Ltd",
    "name_url": "stocks-analysis/ngl-fine-chem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,216.95",
    "chg": 37.6,
    "chgp": "1.73%",
    "dir": 1,
    "prev_price": "2,179.35",
    "mcapval": "1,383.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524774,
    "symbol": "NGLFINE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE887E01022",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "11.77 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ngl-fine-chem-700623-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "NGL Fine Chem Ltd Surges 28.68% in Five Days: Key Drivers Behind the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-ltd-surges-2868-in-five-days-key-drivers-behind-the-rally-3826419",
        "imagepath": "",
        "date": "2026-02-07 16:02:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens at Rs.1,750.00, up 3.33% amid weak Sensex</p>\n                    <p><strong>3 Feb:</strong> Continued gains with Rs.1,823.55 close, Sensex rebounds</p>\n                    <p><strong>4 Feb:</strong> Hits new 52-week high of Rs.2,188.25; surges 20% to upper circuit</p>\n                    <p><strong>5 Feb:</strong> New 52-week high of Rs.2,596, closes with 10.59% gain</p>\n                    <p><strong>6 Feb:</strong> Slight correction to Rs.2,179.35, down 4.47%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,693.60</div></d..."
      },
      {
        "title": "NGL Fine Chem Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ngl-fine-chem-ltd-is-rated-buy-by-marketsmojo-3822373",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NGLFineChemLtd_mojoScore_3822373.png",
        "date": "2026-02-05 10:10:04",
        "description": "NGL Fine Chem Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 February 2026, providing investors with the most up-to-date insights into the company’s performance and outlook."
      },
      {
        "title": "NGL Fine Chem Ltd Hits New 52-Week High of Rs 2596 on 5 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-ltd-hits-new-52-week-high-of-rs-2596-on-5-feb-2026-3822008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NGLFineChemLtd_priceRelatedfactors_3822008.png",
        "date": "2026-02-05 09:45:08",
        "description": "NGL Fine Chem Ltd has surged to a fresh 52-week high of Rs.2596 on 5 Feb 2026, reflecting a robust rally that has propelled the stock well above its previous levels. This milestone underscores the company’s strong momentum in the Pharmaceuticals & Biotechnology sector amid a mixed market backdrop."
      },
      {
        "title": "Are NGL Fine Chem Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-ngl-fine-chem-ltd-latest-results-good-or-bad-3821020",
        "imagepath": "",
        "date": "2026-02-04 19:20:06",
        "description": "NGL Fine Chem Ltd has reported significant financial results for the quarter ended December 2025, showcasing strong operational performance across multiple metrics. The company achieved a consolidated net profit of ₹15.69 crores, reflecting a remarkable year-on-year growth of 1,125.78%, compared to a loss in the same quarter last year. This turnaround is indicative of a successful recovery from previous challenges.\n\nRevenue for the same quarter reached ₹127.51 crores, marking a year-on-year growth of 43.11%. This growth is particularly notable as it surpasses the previous year's modest revenue increase, demonstrating a robust demand for the company's products. The operating profit also saw a substantial rise, with an operating margin of 17.50%, up from 5.72% in the prior year, indicating improved operational efficiency and cost management.\n\nThe company has shown consistent sequential growth, with net profit..."
      },
      {
        "title": "NGL Fine Chem Ltd Reports Strong Quarterly Growth, Upgrades Financial Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-ltd-reports-strong-quarterly-growth-upgrades-financial-outlook-3820569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NGLFineChemLtd_fintrenddot_3820569.png",
        "date": "2026-02-04 11:00:13",
        "description": "NGL Fine Chem Ltd has delivered a robust quarterly performance for December 2025, marking a significant turnaround in its financial trend. The company’s net sales, profitability, and earnings per share have all reached record highs, prompting an upgrade in its Mojo Grade from Hold to Buy. This improvement reflects a very positive shift in operational efficiency and market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "NGL Fine Chem Ltd Hits New 52-Week High of Rs 2,188.25 on 4 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-ltd-hits-new-52-week-high-of-rs-218825-on-4-feb-2026-3820499",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NGLFineChemLtd_priceRelatedfactors_3820499.png",
        "date": "2026-02-04 10:22:14",
        "description": "NGL Fine Chem Ltd has surged to a fresh 52-week high of Rs.2188.25, reflecting robust momentum in the pharmaceuticals and biotechnology sector. This milestone underscores the stock’s significant outperformance relative to its peers and the broader market indices."
      },
      {
        "title": "NGL Fine Chem Ltd Surges 20% to Hit Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-ltd-surges-20-to-hit-upper-circuit-amid-robust-buying-pressure-3820186",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NGLFineChemLtd_stocks_hitting_upper_circuit_3820186.png",
        "date": "2026-02-04 10:00:33",
        "description": "NGL Fine Chem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge today, hitting its upper circuit limit of 20% to close at ₹2,164.20. This sharp rally was driven by robust buying interest, a significant gap-up opening, and sustained investor enthusiasm, marking a new 52-week high for the stock."
      },
      {
        "title": "NGL Fine Chem Q3 FY26: Stellar Turnaround Drives 1,126% Profit Surge",
        "link": "https://www.marketsmojo.com/news/result-analysis/ngl-fine-chem-q3-fy26-stellar-turnaround-drives-1126-profit-surge-3820342",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NGLFineChem_quaterlyResult_3820342.png",
        "date": "2026-02-04 09:51:12",
        "description": "NGL Fine-Chem Limited has delivered a remarkable turnaround in Q3 FY26, with consolidated net profit surging 1,125.78% year-on-year to ₹15.69 crores, marking the strongest quarterly performance in the company's recent history. The Mumbai-based pharmaceutical intermediates manufacturer reported revenue of ₹127.51 crores, up 43.11% YoY, whilst operating margins expanded to 17.50%, signalling a decisive shift in operational efficiency. The stock responded with a dramatic 20% surge on February 4, 2026, closing at ₹2,188.25 and establishing a fresh 52-week high, as investors rewarded the micro-cap company's impressive recovery from the subdued performance witnessed in FY25."
      },
      {
        "title": "Are NGL Fine Chem Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-ngl-fine-chem-ltd-latest-results-good-or-bad-3818959",
        "imagepath": "",
        "date": "2026-02-03 19:19:55",
        "description": "NGL Fine Chem Ltd's latest financial results for the quarter ended September 2025 reveal a complex picture of growth and challenges. The company achieved a record net sales figure of ₹120.26 crores, reflecting a year-on-year growth of 28.65%, which is an acceleration compared to the previous quarter's growth rate. This indicates a strengthening demand for its pharmaceutical ingredients. However, despite this impressive top-line expansion, the net profit reported was ₹9.63 crores, which represents a decline of 1.83% compared to the same quarter last year.\n\nThe operating profit margin improved to 14.27%, up from 12.37% year-on-year, suggesting better operational efficiency. However, the profit after tax (PAT) margin saw a compression to 8.01%, down from 10.49% a year ago, highlighting the challenges in maintaining profitability amidst rising costs and competitive pressures.\n\nThe company's balance sheet has al..."
      }
    ],
    "total": 477,
    "sid": "700623",
    "stock_news_url": "https://www.marketsmojo.com/news/ngl-fine-chem-700623"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Feb-2026",
      "details": "Newspaper Advertisement - Financial Results",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "03-Feb-2026",
      "details": "Outcome of Board Meetiong",
      "source": "BSE"
    },
    {
      "caption": "Disclosure under Regulation 30A of LODR",
      "datetime": "03-Feb-2026",
      "details": "Outcome of Board Meeting - Appointment of Company Secretary and Compliance Officer",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "NGL Fine Chem Ltd has declared <strong>35%</strong> dividend, ex-date: 12 Aug 25",
          "dt": "2025-08-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

NGL Fine Chem Ltd Surges 28.68% in Five Days: Key Drivers Behind the Rally

2026-02-07 16:02:27

Key Events This Week

2 Feb: Stock opens at Rs.1,750.00, up 3.33% amid weak Sensex

3 Feb: Continued gains with Rs.1,823.55 close, Sensex rebounds

4 Feb: Hits new 52-week high of Rs.2,188.25; surges 20% to upper circuit

5 Feb: New 52-week high of Rs.2,596, closes with 10.59% gain

6 Feb: Slight correction to Rs.2,179.35, down 4.47%

Week Open

Rs.1,693.60

Read full news article

NGL Fine Chem Ltd is Rated Buy by MarketsMOJO

2026-02-05 10:10:04

NGL Fine Chem Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 February 2026, providing investors with the most up-to-date insights into the company’s performance and outlook.

Read full news article

NGL Fine Chem Ltd Hits New 52-Week High of Rs 2596 on 5 Feb 2026

2026-02-05 09:45:08

NGL Fine Chem Ltd has surged to a fresh 52-week high of Rs.2596 on 5 Feb 2026, reflecting a robust rally that has propelled the stock well above its previous levels. This milestone underscores the company’s strong momentum in the Pharmaceuticals & Biotechnology sector amid a mixed market backdrop.

Read full news article

Are NGL Fine Chem Ltd latest results good or bad?

2026-02-04 19:20:06

NGL Fine Chem Ltd has reported significant financial results for the quarter ended December 2025, showcasing strong operational performance across multiple metrics. The company achieved a consolidated net profit of ₹15.69 crores, reflecting a remarkable year-on-year growth of 1,125.78%, compared to a loss in the same quarter last year. This turnaround is indicative of a successful recovery from previous challenges. Revenue for the same quarter reached ₹127.51 crores, marking a year-on-year growth of 43.11%. This growth is particularly notable as it surpasses the previous year's modest revenue increase, demonstrating a robust demand for the company's products. The operating profit also saw a substantial rise, with an operating margin of 17.50%, up from 5.72% in the prior year, indicating improved operational efficiency and cost management. The company has shown consistent sequential growth, with net profit...

Read full news article

NGL Fine Chem Ltd Reports Strong Quarterly Growth, Upgrades Financial Outlook

2026-02-04 11:00:13

NGL Fine Chem Ltd has delivered a robust quarterly performance for December 2025, marking a significant turnaround in its financial trend. The company’s net sales, profitability, and earnings per share have all reached record highs, prompting an upgrade in its Mojo Grade from Hold to Buy. This improvement reflects a very positive shift in operational efficiency and market positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

NGL Fine Chem Ltd Hits New 52-Week High of Rs 2,188.25 on 4 Feb 2026

2026-02-04 10:22:14

NGL Fine Chem Ltd has surged to a fresh 52-week high of Rs.2188.25, reflecting robust momentum in the pharmaceuticals and biotechnology sector. This milestone underscores the stock’s significant outperformance relative to its peers and the broader market indices.

Read full news article

NGL Fine Chem Ltd Surges 20% to Hit Upper Circuit Amid Robust Buying Pressure

2026-02-04 10:00:33

NGL Fine Chem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge today, hitting its upper circuit limit of 20% to close at ₹2,164.20. This sharp rally was driven by robust buying interest, a significant gap-up opening, and sustained investor enthusiasm, marking a new 52-week high for the stock.

Read full news article

NGL Fine Chem Q3 FY26: Stellar Turnaround Drives 1,126% Profit Surge

2026-02-04 09:51:12

NGL Fine-Chem Limited has delivered a remarkable turnaround in Q3 FY26, with consolidated net profit surging 1,125.78% year-on-year to ₹15.69 crores, marking the strongest quarterly performance in the company's recent history. The Mumbai-based pharmaceutical intermediates manufacturer reported revenue of ₹127.51 crores, up 43.11% YoY, whilst operating margins expanded to 17.50%, signalling a decisive shift in operational efficiency. The stock responded with a dramatic 20% surge on February 4, 2026, closing at ₹2,188.25 and establishing a fresh 52-week high, as investors rewarded the micro-cap company's impressive recovery from the subdued performance witnessed in FY25.

Read full news article

Are NGL Fine Chem Ltd latest results good or bad?

2026-02-03 19:19:55

NGL Fine Chem Ltd's latest financial results for the quarter ended September 2025 reveal a complex picture of growth and challenges. The company achieved a record net sales figure of ₹120.26 crores, reflecting a year-on-year growth of 28.65%, which is an acceleration compared to the previous quarter's growth rate. This indicates a strengthening demand for its pharmaceutical ingredients. However, despite this impressive top-line expansion, the net profit reported was ₹9.63 crores, which represents a decline of 1.83% compared to the same quarter last year. The operating profit margin improved to 14.27%, up from 12.37% year-on-year, suggesting better operational efficiency. However, the profit after tax (PAT) margin saw a compression to 8.01%, down from 10.49% a year ago, highlighting the challenges in maintaining profitability amidst rising costs and competitive pressures. The company's balance sheet has al...

Read full news article

View All News